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Summary
RASSF1A is a tumor suppressor gene that is inactivated by
hypermethylation of its promoter region in most types of
human cancers [1–3]. The incidence of spontaneous or
induced tumors is significantly higher in Rassf1a2/2 mice
than in wild-type mice, confirming the tumor suppressor
function of RASSF1A [4, 5]. RASSF1A promotes apoptosis
mainly through its interaction with the proapoptotic serine/
threonine STE20-like kinases MST1 and 2 [6, 7]. However,
Rassf1a2/2 mice do not show overt signs of deregulated
apoptosis [4, 5], suggesting that other RASSF1A effectors
are also critical for tumor suppression. In a proteomics
screen, we identified RAN GTPase, MST1 and 2 kinases,
and a- and g-tubulin as RASSF1A-interacting proteins. We
show that RASSF1A-induced microtubule hyperstability,
a hallmark of RASSF1A expression [8, 9], is RAN-GTP depen-
dent. RASSF1A promotes the accumulation of the GTP-
bound form of RAN via the MST2-induced phosphorylation
of RCC1. Depletion of RASSF1A results in mislocalization of
RCC1 to the mitotic spindle and spindle poles, leading to
mitotic spindle abnormalities and prometaphase block. A
similar mitotic delay is also observed with MST2 depletion.
These findings reveal a mechanism for how RASSF1A
controls microtubule stability and for how its loss compro-
mises the integrity of the mitotic spindle, leading to aneu-
ploidy and tumorigenesis.
Results and Discussion
RAN GTPase Is a Novel RASSF1A-Interacting Protein
In order to identify additional factors that mediate RASSF1A-
induced microtubule hyperstability, we immunoprecipitated
FLAG-RASSF1A transiently expressed in HEK293 cells and
identified interacting proteins via 2D liquid chromatography-
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was identified as a novel RASSF1A-interacting protein in this
screen. RAN is a small GTPase that is crucial in the regulation
of nucleocytoplasmic transport [11] as well as assembly of
the mitotic spindle [12]. RAN GTPase was specifically pulled
down by GST-RASSF1A, but not by GST alone (Figure 1A).
Endogenous RASSF1A and RAN coprecipitated in HCT116
colorectal cancer cells (Figure 1B), confirming that the
RASSF1A-RAN interaction occurs at physiological levels.
This interaction appears to be direct, because bacterially
expressed and purified RASSF1A (GST-RASSF1A) and RAN
interacted with each other in vitro (Figure 1C). When lysates
from HEK293 cells transiently expressing GST-RASSF1A
were loaded with the nonhydrolyzable GTP analog GTPgS or
GDP prior to GST pull-down, RASSF1A interacted preferen-
tially with RAN-GTP (Figure 1D). In order to map the RASSF1A-
RAN interaction sites, GST-RAN-Q69L was coexpressed with
full-length HA-RASSF1A and different truncated mutants.
Only full-length HA-RASSF1A, HA-RASSF1A 1–285 aa, and to
a lesser extent HA-RASSF1A 120–340 aa coprecipitated with
GST-RAN (Figure 1E), suggesting that RASSF1A residues
120–285 aa mediate the interaction with RAN. The weak inter-
action of RASSF1A 120–340 aa with RAN further suggests
that the C1 domain, located between aa 52 and 101, partici-
pates in but is not essential for RASSF1A-RAN interactions. A
role for the C1 domain became more evident when we analyzed
a mutation in the C1 domain of RASSF1A (C65R) that abrogates
its ability to hyperstabilize microtubules [8]. This mutation also
inhibited the interaction with RAN, whereas other RASSF1A
mutations did not compromise RAN binding (see Figure S1
available online). This observation suggests that both the C1
domain and the RA domain are necessary for efficient RAN
binding and that this interaction in turn is important for
RASSF1A-microtubule association. In order to examine the
cellular localization of the RASSF1A-RAN interaction, immuno-
fluorescence staining of RASSF1A and RAN in mitotic HeLa
cells was performed. Because endogenous RASSF1A is diffi-
cult to detect, we rigorously ascertained the specificity of the
RASSF1A antibody (Figure S2). As expected, the majority of
the RAN signal was associated with chromatin. However, as
reported previously [13], a proportion of RAN also existed at
the spindle poles, where it colocalized with endogenous
RASSF1A (Figure 1F).
RASSF1A-Induced Microtubule Hyperstability Is RAN-GTP
Dependent
Next, we examined whether the RASSF1A-induced microtubule
hyperstabilization is RAN-GTP dependent. For this, we utilized
the tsBN2 cell line,which harbors a temperature-sensitivemuta-
tion in the RAN guanine nucleotide exchange factor RCC1 [14].
This mutation causes the degradation of RCC1 when cells are
grown at restrictive temperature (39.5C), effectively reducing
RAN-GTP levels (Figure S3A). Nocodazole treatment at the
permissive temperature (Figure 1G, left panel) did not cause
any noticeable difference in typical RASSF1A-induced microtu-
bule hyperstabilization [8]. At the restrictive temperature,
however, RASSF1A-induced microtubule hyperstabilization
was lost and the GFP-RASSF1A signal on the microtubules
Current Biology Vol 19 No 14
1228A B C D E
F G
H I J
-
-
-
-
-
-
-
-
-
-
-
Figure 1. RASSF1A Interacts with RAN-GTP
(A) GST-RASSF1A interacts with endogenous RAN. GST or GST-RASSF1A proteins transiently expressed in HEK293 cells were pulled down and immuno-
blotted (IB) for associated RAN GTPase.
(B) RASSF1A and RAN GTPase interact in vivo. Endogenous RASSF1A and RAN GTPase were coimmunoprecipitated from HCT116 lysates with the respec-
tive antibodies. The input lane does not show a band for RASSF1A because the antibody used in the immunoprecipitation (eb114) does not efficiently detect
RASSF1A levels in lysates. Our in-house antibody was not suitable for use in this blot because of cross-reactivity with the heavy and light chains of the anti-
bodies used in the immunoprecipitation.
(C) Bacterially purified RAN GTPase and GST-RASSF1A interact directly in vitro.
(D) RASSF1A has higher affinity for RAN-GTP. Equal volumes of lysates generated from HEK293 cells transiently expressing GST-RASSF1A were either
treated with 1 mM GDP or 100 mM GTPgS for 30 min at 30C prior to GST pull-down and western blotting.
(E) Mapping the sites of interaction between RASSF1A and RAN GTPase.
(F) Colocalization of endogenous RASSF1A (green) and RAN GTPase (red) in methanol-fixed mitotic HeLa cells (DNA shown in blue).
(G) RASSF1A-mediated microtubule hyperstability is RAN dependent. tsBN2 cells were treated as detailed in Supplemental Experimental Procedures; only
nocodazole-treated cells are shown. Scale bars represent 10 mm.
(H) Expression of FLAG-RASSF1A and FLAG-MST2 enhances the ability of GST-RAN to associate with the RAN-GTP-specific binding protein RANBP1.
(I) siRNA-mediated knockdown of MST2 interferes with GST-RAN’s ability to interact with RANBP1.
(J) Top: RASSF1A ability to hyperstabilize the microtubules (MT) is MST2 dependent. Error bars represent the standard deviation of three experiments. *p =
0.015 and 0.005 by t test for Luc siRNA versus MST2-1 and MST2-2 siRNAs, respectively. Bottom: the extent of MST2 knockdown was verified by western
blotting.
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1229Figure 2. MST2 Phosphorylates RCC1 In Vitro and In Vivo
(A) HEK293 cells were transfected with FLAG-MST2 or the kinase-inactive mutant FLAG-MST2-K56R. MST2 and MST2-K56R were immunoprecipitated with
FLAG-agarose beads and incubated with recombinant RCC1 protein as substrate in the presence of [g-32P]ATP. After separation on SDS-PAGE, the gel was
Coomassie stained, and phosphorylation was detected by phosphoimaging. CB indicates Coomassie-stained gels.
(B) Purified GST-MST2 (Cell Signaling) can also directly phosphorylate recombinant RCC1.
(C) FLAG-RCC1 and FLAG-RCC1 S2/11A were purified from phosphatase-treated HEK293 lysates (lambda phosphatase, Cell Signaling; 100 U/50 ml lysate at
30C for 20 min) via FLAG-agarose and used in an in vitro kinase assay with 27 mU recombinant MST2 as a kinase.
(D) Immunoprecipitated FLAG-MST1 and MST2 were used to phosphorylate purified RCC1.
(E) Knockdown of MST2 by siRNA oligonucleotides results in reduced phosphorylation at RCC1 S2/11A. Cells were transfected with siRNA oligonucleotides
against MST2 or Luc (control). Endogenous RCC1 proteins were pulled down with GST-RAN-T24N and western blotted with the indicated antibodies.
(F) The effect of modulating RAN GTP/GDP ratios on MST2 activity. GST, GST-RAN-T24N, and/or GST-RAN-Q69L were expressed in the indicated combi-
nations in HEK293 cells. Forty-eight hours later, the cells were lysed, and immunoprecipitated endogenous MST2 was assayed for its ability to phosphor-
ylate recombinant His-RCC1 in vitro.
(G) The endogenous MST2-RASSF1A interaction is disrupted by RAN-GTP. One milligram of each HeLa cell lysate was immunoprecipitated with MST2 anti-
body in the presence of 2 mM preloaded RAN-GTPgS or RAN-GDP before immunoblotting with the indicated antibodies.became punctate or diffuse (Figure 1G, right panel; only noco-
dazole-treated cells are shown). Furthermore, GTPgS loading
of lysates selectively increased the interaction between
GFP-importin b and GST-RAN whereas GDP loading had no
effect, showing that importin b can be used as a probe to
detect RAN-GTP (Figure S3B). Transfection of FLAG-RASSF1A
increased the association betweenGST-RANand GFP-importin
b expressed in HEK293 cells (Figure S3C), indicating that
RASSF1A increases RAN-GTP levels. Furthermore, GST-impor-
tin b also associated with higher levels of endogenous RAN, i.e.,
RAN-GTP, in the presence of HA-RASSF1A (Figure S3D). Taken
together, these results suggested that RASSF1A can induce
RAN-GTP loading and that the ability of RASSF1A to stabilize
microtubules depends critically on RAN-GTP.
MST2 Mediates the Effects of RASSF1A
on the RAN Pathway
In our proteomic screen, we found RASSF1A associating with
both RAN and MST1/2. To elucidate the role of MST2, we tested
the effect of MST2 expression on RAN-GTP levels in HEK293
cells. RANBP1 is a RAN-binding protein that binds specificallyto RAN-GTP [15, 16] and hence can be used to monitor RAN-
GTP levels. Expression of FLAG-MST2 enhanced RAN-GTP
levels, and coexpression of FLAG-RASSF1A and FLAG-MST2
cooperated to further increase the levels of RAN-GTP (Fig-
ure 1H). Conversely, siRNA-mediated knockdown of MST2
strongly reduced both the basal and RASSF1A-induced levels
of RAN-GTP (Figure 1I). These results suggested that MST2
cooperates with RASSF1A to enhance RAN-GTP levels.
Because high RAN-GTP levels are responsible for RASSF1A-
induced microtubule hyperstability, depletion of MST2 should
interfere with the ability of RASSF1A to enhance RAN-GTP
levels and consequently reduce its ability to protect micro-
tubules against nocodazole-induced depolymerization. Cells
with FLAG-RASSF1A expression exhibited the typical circular
bundles of stable microtubules (Figure S4). Depletion of MST2
(Figure 1J; Figures S4 and S5) caused a significant reduction in
the number of cells with stable microtubules (Figure 1J; p =
0.015 and 0.005 by t test for Luc siRNA versus MST2-1 and
MST2-2 siRNA, respectively). This indicated that MST2 is
required for RASSF1A-induced RAN-GTP loading and microtu-
bule hyperstability, prompting further investigation of this role.
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Figure 3. RASSF1A Regulates RCC1 Localization in an MST2-Dependent Manner
(A and B) RASSF1A traps RCC1 in the cytoplasm in an MST2-dependent manner (A) that is inhibited by the expression of the RAN-Q69L mutant (B). Error
bars represent the standard deviation of three experiments.
(C–E) Representative immunofluorescence images used to obtain the quantifications shown in (A) and (B).
(F) Mitotic cells from Luc or RASSF1A siRNA-transfected HeLa cells were methanol fixed prior to staining with RCC1 antibody (red) and a-tubulin antibody
(green). DAPI was used to stain DNA. Scale bar represents 10 mm.
(G) The effect of RASSF1A depletion on MST2’s ability to phosphorylate RCC1 in mitotic cells. HeLa cells were transfected with the indicated siRNA oligo-
nucleotides and arrested at mitosis by nocodazole. Endogenous MST2 was immunoprecipitated and used in the kinase assay as in Figure 2.MST2 Phosphorylates RCC1
It was recently shown that in mitotic cells, RCC1 localization,
chromatin association, and activity in generating RAN-GTP
are controlled by phosphorylation of RCC1’s N terminus, in
particular serines 2 and 11, by CDK1 [17, 18]. We therefore
tested whether purified recombinant human His-tagged RCC1
was a substrate for MST2. FLAG-tagged MST2 immunoprecip-
itated from HEK293 cells was able to autophosphorylate and
also efficiently phosphorylated His-RCC1, whereas the kinase-
dead mutant MST2-K56R failed to phosphorylate itself or
His-RCC1 (Figure 2A). Recombinant purified MST2 also could
phosphorylate purified His-RCC1, suggesting that RCC1 is
a direct substrate (Figure 2B). The ability of MST2 to phosphor-
ylate a mutant FLAG-RCC1, S2/11A, was greatly reduced
(Figure 2C), demonstrating that S2/11 sites are targeted by
MST2. Using an antibody generated against phospho-S2/11
in RCC1 [18], we found that these two residues were also
efficiently phosphorylated by MST1 and MST2 (Figure 2D),
further supporting that S2 and/or S11 are genuine MST2 phos-
phorylation targets. Furthermore, we utilized the in vitro puri-
fied GST-RAN-T24N mutant, which has very high affinity for
RCC1, to enrich endogenous RCC1 from HEK293 cell lysates
and examine its phosphorylation status with the phospho-
S2/11 RCC1 antibody. RCC1 was phosphorylated on S2/11 inasynchronous HEK293 cells (Figure 2E). However, the levels
of phospho-RCC1 decreased after MST2 knockdown (Fig-
ure 2E), further supporting that RCC1 is an endogenous
MST2 substrate.
It is important to understand the effect of RASSF1A expres-
sion on MST2-mediated RCC1 phosphorylation as well as to
examine the consequences of RAN-GTP and RAN-GDP levels
on this process. Therefore, we immunoprecipitated endoge-
nous MST2 from lysates of HEK293 cells expressing GST-
RAN-T24N, GST-RAN-Q69L, or GST alone in the presence or
absence of RASSF1A (Figure 2F). Interestingly, in the absence
of RASSF1A, endogenous MST2 kinase activity toward re-
combinant His-RCC1 was significantly higher when the consti-
tutively active RAN-Q69L mutant was expressed as compared
to the dominant-negative RAN-T24N mutant. This stimulation
of MST2 kinase activity by RAN-Q69L would constitute a
positive feedback loop from RAN to MST2. The presence of
RASSF1A resulted in increased MST2 activation and RCC1
phosphorylation, except where GST-RAN-Q69L was coex-
pressed. The latter result was unexpected and suggests that
in the presence of RASSF1A, a negative feedback loop oper-
ates from RAN-GTP to MST2. Because RASSF1A interacts
with and activates MST2 in cells [6, 7, 19], we tested the possi-
bility that the disruption of the RASSF1A-MST2 complex by
RASSF1A and the RAN GTPase Pathway
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Figure 4. Knockdown of RASSF1A Causes Mitotic Delay
(A) Mitotic cells from different treatments were analyzed for the time between nuclear envelope breakdown and anaphase (n = 15). The bar chart represents
the percentage of cells that divided within the time frame shown in the x axis.
(B) Following visualization of a-tubulin and DNA, the percentage of cells at the different stages of the mitotic cycle was determined by scoringw200 cells.
Error bars represent the standard deviation of three experiments. There was a statistically significant difference (p < 0.05 by t test) at the prometaphase stage
between control and RASSF1A or MST2 siRNA-transfected cells.
(C) Mitotic delay is also evident by the elevated levels of phosphohistone H3 in RASSF1A- or MST2-depleted HeLa cells. a-tubulin was used as a loading
control.activated RAN-GTP could be part of this feedback loop. Inter-
estingly, RAN-GTPgS, but not RAN-GDP, interfered with the
endogenous RASSF1A-MST2 association (Figure 2G), sug-
gesting that activated RAN may exert the negative feedback
by disrupting the interaction between RASSF1A and MST2.
RASSF1A Regulates RCC1 Localization in Interphase
and Mitotic Cells
During mitosis, RCC1 phosphorylation at S2/11 in its nuclear
localization signal releases RCC1 from importin a to permit
subsequent RCC1 mobility and chromatin association [17,
18]. In interphase cells, the inhibition of importin a binding by
nuclear localization signal phosphorylation would be expected
to compromise the nuclear transport of RCC1 and lead to accu-
mulation in the cytosol. Because RASSF1A expression could
stimulate MST2-mediated RCC1 phosphorylation on S2/11 in
interphase cells (Figure 2), we investigated how RASSF1A
expression affects RCC1 localization in interphase cells
(Figure 3). FLAG-RCC1 was coexpressed with HA-RASSF1A
in HeLa cells and examined by immunofluorescence. HA-
RASSF1A expression trapped a substantial fraction of FLAG-
RCC1 in the cytoplasm (Figures 3A–3E). Quantification of
this effect showed that around 65% of cells expressing
HA-RASSF1A and FLAG-RCC1 exhibited this phenotype,
compared to only 10% in GFP- and FLAG-RCC1-transfected
cells (Figures 3A, 3C, and D). The cytosolic retention of RCC1
was dependent on MST2 and S2/11 phosphorylation, because
either siRNA-mediated knockdown of MST2 or transfection of
RCC1-S2/11A mutant efficiently blocked the RASSF1A-
induced retention of RCC1 in the cytosol (Figures 3A and 3E).
Thus, in interphase cells, the phosphorylation of S2/11 by
MST2 interferes with nuclear transport of RCC1. RAN-Q69L
expression interfered with RASSF1A-induced cytosolic reten-
tion (Figure 3B), confirming the negative feedback loop hypoth-
esis based on the findings that RAN-Q69L inhibited bothRASSF1A-MST2 association and RASSF1A-induced MST2
kinase activity toward RCC1 (Figures 2F and 2G). Given the crit-
ical role of S2/11 phosphorylation for RCC1 function during
mitosis [17, 18], we also tested the effects of RASSF1A knock-
down on RCC1 localization in mitotic HeLa cells (Figure 3F).
RCC1 was normally associated with the chromatin. However,
in RASSF1A-depleted cells, RCC1 associated with the spindles
or the spindle poles, with generally less signal associated with
the chromosomes (Figure 3F, lower panel; 65% of metaphase
cells counted, as opposed to 10% in control transfected cells;
20 metaphase cells counted over two independent experi-
ments). Knockdown of RASSF1A in HeLa cells also reduced
the ability of MST2 to phosphorylate RCC1 (Figure 3G).
Given such a dramatic effect on RCC1 localization, it was
expected that RASSF1A depletion would be associated with
mitotic abnormalities (Figure 4). Time-lapse video microscopy
of HeLa cells stably expressing GFP-histone H2B [20, 21]
following RASSF1A depletion showed that the majority of cells
failed to proceed into anaphase even after 4 hr of microscopy
(Figure 4A; Figure S6A; Movies S1 and S2). Furthermore,
RASSF1A depletion was associated with a significant accumu-
lation of cells at the prometaphase stage (Figure 4B). Impor-
tantly, this effect could be mediated through MST2, because
knockdown of MST2 caused a similar extent of prometaphase
delay (Figure 4B). The presence of this mitotic delay was further
supported by the enhanced phosphorylation of histone H3 in
RASSF1A- or MST2-depleted cells compared to controls
(Figure 4C). Further mitotic abnormalities observed are detailed
in Figure S6.
The RASSF1A/MST2/RAN GTPase Complex
The identification of RAN GTPase and MST2 in complex with
RASSF1A suggests novel functions for MST2 and provides
insight into RASSF1A mechanisms of action. In interphase
cells, RASSF1A overexpression traps a fraction of RCC1 in
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nuclear localization signal of RCC1 mediated by cytoplasmic
RASSF1A-associated MST2, which would prevent binding to
importin a and shuttling into the nucleus. This could augment
the normally low levels of RAN-GTP in the cytosol, permitting
RASSF1A to stabilize interphase microtubules. In mitosis,
the phosphorylation of RCC1 releases it from the importin
complex, allowing it to stably attach to the chromosomes.
Here, RCC1 generates RAN-GTP, causing the steep gradient
of RAN-GTP/RAN-GDP that is required for mitotic spindle
formation [22]. The knockdown of RASSF1A in mitotic cells
reduces the ability of MST2 to phosphorylate RCC1, abro-
gating the stable association of RCC1 with chromosomes
and causing redistribution to spindle poles instead (Figure S7).
In normal mitosis, this is where both RASSF1A and a portion of
RAN are found (Figure 1F). This gives rise to an interesting
speculation (Figure S8) that during mitosis, the spindle pole
may serve as a source for MST2 activation, which phosphory-
lates RCC1, thereby promoting stable binding of RCC1 to
chromosomes. The ability of RAN-GTP to efficiently disrupt
the RASSF1A-MST2 interaction (Figure 2G) could serve as a
feedback mechanism that constrains the activation of RCC1
both in time and in space by diverting active RCC1 away
from the spindle poles to the chromosomes. Thus, the down-
regulation of RASSF1A expression in many human cancers
may contribute to the commonly observed chromosomal
instability and subsequent tumorigenesis.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures, eight
figures, and two movies and can be found with this article online at http://
www.cell.com/current-biology/supplemental/S0960-9822(09)01235-4.
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